Challenging auxotrophs on metabolites that are precursors of a biosynthetic step involving a mutated enzyme has revealed a new class of suppressor mutations which act by derepressing a minor enzyme activity not normally detected in the wild-type strain. These indirect, partial suppressor mutations which allow isoleucine auxotrophs to grow on homoserine or threonine have been analyzed to determine their effect on enzymes involved in the biosynthesis of these amino acids. It has been found that one class of these suppressor mutations (sprA) leads to the derepression of homoserine kinase, homoserine dehydrogenase, and a minor threonine dehydratase that is not sufficiently active to be detected in the wild-type strain. The gene encoding this second threonine dehydratase activity has been found to be located between the structural genes for homoserine kinase and homoserine dehydrogenase. The results of these experiments indicate that plating of auxotrophs on precursors of a biosynthetic step involving mutated enzymes could prove to be a valuable method for the detection of regulatory mutants as well as a possible tool in studying the evolution of biochemical pathways.
The term "indirect suppressor" has been used by Gorini and Beckwith (5) to describe classes of allele nonspecific mutations which circumvent rather than repair the effect of a primary mutation.
One aspect of indirect suppression that has received little attention is that resulting from alterations in control mechanisms of the cell.
This type of suppressor could act by causing derepression of an existing pathway, so that an enzyme partially inactivated by a minor missense mutation would be produced at a sufficiently high level to allow the cell to grow. The suppressor might also act by derepressing a normally repressed or vestigial pathway that contains an enzyme that could substitute for the enzyme altered by mutation. This enzyme might be one that normally catalyzes a different reaction in the cell but has a low degree of specificity for the substrate of the altered enzyme. The fact that this enzyme is now present in high levels might allow it to overcome the effect of the original mutation. If the original mutation resulted in a partial block due to a minor missense mutation, for example, derepression of enzymes catalyzing the production of precursors might also lead to suppression. In this case the suppressor ' This report is part of a thesis presented by D. Vapnek to the University of Miami in partial fulfillment of the requirement for a Ph.D. degree.
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would act by increasing the substrate level available to a partially active enzyme.
By studying these types of suppressor mutations, one could not only learn about the relationship of pathways within the cell but could also study a variety of problems relating to metabolic control mechanisms.
If the suppressor mutants that were selected proved to be regulatory mutants, one could possibly have a method to obtain mutations in the translational machinery of the cells, since experiments from several laboratories have demonstrated the involvement of components of translation in metabolic control (4, 10, 12) .
In the present study, a class of indirect suppressors that partially reverse the effects of mutations leading to an absolute requirement for isoleucine have been studied. The phenotypic expression of these suppressor mutations is that they confer the capacity for growth on homoserine or threonine as well as isoleucine to these isoleucine auxotrophs (14) . These suppressor mutations act by derepressing a threonine dehydratase (TD) activity not normally detected in the wild-type cells. This secondary TD activity is encoded between the structural gene for homoserine kinase and the structural gene for homoserine dehydrogenase. A brief account of this work was presented by Greer and Vapnek (Bac-VAPNEK AND GREER MATERIALS AND METHODS Strains, growth of cells, preparation of cell extracts, determination of protein concentration, and methods of genetic mapping were presented in a previous paper (14) .
Enzyme assays. Homoserine kinase (EC 2.7.1.39), O-phosphohomoserine formed in the adenosine tfiphosphate plus Mg2+-dependent phosphorylation of homoserine, was assayed at pH 7.0 by the method of Wormser and Pardee (15) . O-phosphohomoserine was separated from the neutral amino acids on Dowex 50W-X8 cation-exchange resin and assayed by the ninhydrin method of Moore and Stein (9) . Specific activity is defined as micromoles of amino acid formed per hour per milligram of protein.
Homoserine dehydrogenase (EC 1. Table 1 is shown the activity of homoserine kinase (HK) in the wild-type strain (+) and in an isoleucine auxotroph (ile-3) harboring the allele nonspecific suppressors, sprA or sprB, either singly or in combination. The effect of these suppressors when there is a mutation in HK (thrA auxotroph) is also shown, as is the effect of sprA in the prototrophic strain (ile+,sprA). As can be seen from this table, the sprA mutation leads to approximately a fivefold derepression of HK, either in the presence or absence of a structural gene mutation affecting TD. The sprB mutation has no significant effect on the HK activity in these strains, either alone or in combination with an sprA mutation. A structural gene mutation in thrA abolishes all HK activity Since HK has been found to be inhibited by the end-product threonine in Escherichia coli (15) , it was considered of interest to test whether this enzyme was also controlled by end-product inhibition in Bacillus subtilis and, if so, whether the presence of sprA had any effect on this end product inhibition. Table 3 describes the results of those experiments. The degree of inhibition found in wildtype B. subtilis was comparable to that found in E. coli. HK activity of the strains containing sprA or sprB mutations is inhibited to the same extent as that of the wild type, even though the HK activity is 5 to 15 times higher in these mutants. This finding supports the conclusion that the increased HK activity found in these strains is due to derepression of HK and not to an increase in some other kinase that is able to phosphorylate homoserine.
Genetic mapping experiments revealed that a series of mutant alleles that lead to a requirement for methionine and threonine, or homoserine, are linked to the mutational sites in the gene encoding HK (Fig. 2) . These mutants were subsequently found to lack homoserine dehydrogenase (HD). The close linkage of these mutational sites to HK, as well as the biosynthetic relationship of these enzymes, prompted an examination The presence of the sprA mutation in these strains led to derepression of HD, whereas the sprB mutation appeared to have no effect on this enzyme (Table 4 ). The effect of the sprA mutation on homoserine dehydrogenase is evident in both the presence and absence of the mutated TD allele and is comparable to the results found with HK ( Table 1 ). The HD activity encountered in the sprA strains with a block in TD, which was higher than the HD activity in the ile+,sprA strain, may be correlated with the phenomenon of derepression of HD by threonine which occurs to a greater extent in an ile-mutant than in wild-type cells (Skarstedt and Greer, unpublished data). Threonine would be expected to accumulate more readily in ile-mutants that are derepressed for the enzymes involved in threonine synthesis. Note that the sprA-1S mutation, which leads to conditional derepression of the minor TD and HK, also results in the conditional derepression of HD.
One other enzyme of the aspartate family, aspartokinase (AK), was also assayed in several wild-type strains as well as several mutants containing the sprA or sprB mutations. AK activity was found to vary over a wide range with several different wild-type strains tested. These studies utilized cells grown in minimal medium as well as those grown in minimal medium supplemented with lysine, homoserine, threonine, or isoleucine. The presence of these amino acids had no effect on the activity of this enzyme. No mutants in which AK has been affected are available in B. subtilis, and its structural gene has not been located with respect to the structural genes for HK and HD.
The results of the above experiments indicate that the presence of the sprA mutation leads to derepression of two enzymes which are encoded by closely linked genes, HK and HD, as well as a TD activity that was about 2 to 3% of the wildtype level. The activities of these three enzymes are at least five to eight times higher than the level found in an ile auxotroph possessing a mutation in the structural gene of the major threonine dehydratase. The results presented in a previous paper (14) indicated that the TD activity present in these strains was different from the normal biosynthetic TD. Based on these findings, one possible explanation of the mechanism of action of the sprA mutation is that it causes derepression of a second TD which is specified by a gene linked to the genes for HK and HD. To test this hypothesis, strains containing both a sprA mutation and a mutation in the structural gene for TD (phenotype IHT) were mutagenized with nitrosoguanidine, plated on isoleucine, and replicated on plates containing homoserine or isoleucine. This procedure resulted in several mutants that were able to grow only in the presence of isoleucine. The loss of the ability to grow on homoserine in these strains could have been due either to a reverse mutation in the sprA gene or to a mutation in the gene for the proposed second or minor TD (tdm). Two of these mutant strains were investigated further to determine whether either of these possibilities was correct. Enzymatic analysis of these strains revealed that HD and HK were still derepressed, but there was now no detectable TD activity (<0.01 specific activity), suggesting that the sprA mutation was still present (confirmed by genetic analysis, below) but that the second TD had been inactivated by mutation.
Genetic experiments. Table 5A shows representative cotransformation experiments whereby the Table 5B . More extensive genetic data upon which the map in Fig. 2 is based, obtained in part from reciprocal transformation studies, are shown in Table  6 . The potency of the deoxyribonucleic acid (DNA) in linked transformation was determined by employing strain his-31,ind-168 as a receptor. The potency of the DNA was also assayed by utilizing the transformation of sulfanilamide resistance as an internal standard. In Table 7 is shown a transformation experiment in which the presence of the sprA mutation in strain ile-3,tdm-56 and in strain ile-3,tdm-3 is confirmed. Not only are HD and HK derepressed in these mutants, but the sprA mutation can be readily transformed to a recipient "ile only" mutant, so that transformants can grow on homoserine or threonine. Thus the inability of these nitrosoguanidine-induced mutants to grow on homoserine or threonine is due to a mutation in the structural gene encoding the minor TD.
In Table 8 is shown the genetic evidence that DNA from cells containing a mutation in the structural gene of the major TD possesses an intact, unlinked gene for the minor TD. This DNA was utilized to transform sprA,ile-3,tdmmutants, which can only grow upon supplementation with isoleucine, to the capacity to grow on homoserine or threonine as well as isoleucine. In this table, the close linkage of the sprB mutational site to the tdm gene is also shown by the high incidence of cotransfer of these two genetic markers. Table 9 shows the extent of cotransfer of tdmwith thrA + mutational sites. This cotransfer does not allow a thrA-J,le-,tdm+,sprA cell (which can grow on threonine) to grow on homoserine, whereas such a transformant can readily grow on isoleucine. The results obtained are in accord with the genetic map shown in Fig. 2 . Table 10 shows a representative experiment demonstrating linkage of tdm-3 and tdm-56 mutational sites to each other and to the region encoding HK and HD. If the thrA-marker is close to tdm+, then as tdm+ is transformed to enable a recipient cell to grow on plates supplemented with homoserine or threonine, the cotransfer of thrA -will not enable such a cell to grow on homoserine, whereas it can grow on threonine. Thus the tdm-3 mutational site is closer to thrA than is the tdm-56 mutational site, because the difference between the number of transformants on the plates supplemented with homoserine and those supplemented with threonine is greater when the tdm-3 mutational site is utilized. In a similar manner, a hom mutational site is cotransferred with tdm-56+ more readily than with the tdm-3+ genetic marker, since there is a greater number of colonies on the homoserine plates than on the threonine plates when tdm-56+ is utilized as the genetic marker. Cotransfer of hom mutational sites with tdm+ does not enable a cell to grow on threonine plates, but it is capable of growth on plates supplemented with homoserine.
To prove that these differential counts occur only when linked auxotrophic markers such as hom and thrA are cotransferred, DNA of metB, tyr-17, leu-18, ade-21, and phe-26 auxotrophic mutants that also contained sprA and ile-3 mutational sites were utilized. No significant difference in the number of transformants was obtained on appropriately supplemented homoserine or threonine plates, indicating that these auxotrophic markers are not cotransformed with tdm+ as are hom and thrA mutational sites. Table 11 shows the extent of linkage of sprB to three thrA mutational sites. It is essential that thrA+ and the sprB mutational site be cotransformed to enable a thrA-,ile-receptor to grow on plates supplemented with homoserine. Note that the more distant the thrA mutational site from the region encoding tdm, the lower the extent of cotransformation, as indicated by a comparison with the transformation of the single marker, thrA+, as determined on a plate supplemented with isoleucine.
The genetic and enzymatic studies lead to the conclusion that a second or minor TD (tdm), that is located between the genes encoding HK and HD, is present in B. subtilis. When this minor TD is derepressed so that the enzyme activity is elevated to a level that is of physiological significance, HD and HK are concomitantly derepressed.
Threonine inhibition. In contrast with results with E. coli, high concentrations of threonine inhibit wild-type strains of B. subtilis. The auxotrophic, derepressed strain sprA, ile-, which can utilize threonine for growth, is initially inhibited by threonine, as determined by growing the bacteria on limiting concentrations of isoleucine.
The slow conversion of threonine to a-ketobutyrate relieves the inhibition and results in the formation of isoleucine. Methionine overcomes the inhibition by threonine in the wild type and in the sprA, ile-3 mutant.
If sprA,ile mutants also contain a mutational site in the gene encoding the minor TD, there is a further increase in their sensitivity to inhibition by threonine. These studies utilizing centrations of isoleucine (75 to 400 Ag/ml), presumably due to end product inhibition or repression of TD. This inhibition of growth by threonine in the presence of high concentrations of isoleucine occurs to an even greater extent in tdm mutants. As expected, ile-mutants, lacking the isoleucine sensitive major TD, show no increased sensitivity to inhibition by threonine when they are grown in medium containing high concentrations of isoleucine.
The complete reversal of threonine inhibition by 2 gg of valine per ml (14) may be explained, in turn, by the fact that valine antagonizes isoleucine inhibition of the major TD, since the effect of valine on threonine inhibition is diminished when the cells are grown in medium containing high concentrations of isoleucine; furthermore, valine has no effect on threonine inhibition in mutants lacking the major TD. Increasing concentrations of valine reverse the effect of isoleucine in sprA,ile+ cells.
To determine the role of enzymes in these strains other than threonine dehydratase that could modify threonine such as threonine aldolase or threonine dehydrogenase, for example, studies were pursued to determine whether threonine could serve as a nitrogen or carbon source under conditions utilizing a range of limiting concentrations of ammonium sulfate or glucose. In spite of the sensitivity of these growth experiments, the results with TD--, tdm-double mutants and other appropriate mutants indicated that there is no other route by which threonine can be modified to serve as a nitrogen or carbon source in these strains. Threonine served as a nitrogen source in the wild-type strain, to a lesser extent in the ile,sprA mutant, to a very limited extent in the ile mutant, and not at all in the ile, tdm mutant, correlating quantitatively with the total threonine dehydratase activity possessed by these strains. Because extremely high concentrations (0.3 to 0.5 mg/ml) of threonine were used in these studies, similar experiments in which low concentrations (25 ,ug/ml) of methionine were added were also pursued so that the role of catabolism of threonine could be examined without extensive inhibition of the cells. The fact that the normal biosynthetic TD is controlled by the level of isoleucine in the cell via end-product inhibition as well as by multivalent end-product repression, whereas the minor TD activity appears to act independently of the isoleucine concentration (little end-product inhibition and no derepression by limiting isoleucine), allows speculation concerning the physiological significance of this enzyme as well as the possible evolution of TD.
The presence of a TD activity which is coordinately controlled with HK Kemper and Margolin (8) described a system in which structural gene mutants (in leuD) af-encoded between the genes encoding HD and HK is that it represents a secondary catalytic activity of threonine synthetase. Threonine synthetase, because of its position in the pathway of threonine biosynthesis, would be expected to be located in this region.
Both the TD and threonine synthetase reactions would be expected to involve a similar enzyme-bound pyridoxal phosphate-Schiff base intermediate. One could therefore hypothesize that threonine synthetase might catalyze the dehydrative deamination of threonine to aKB and that a derepression of threonine synthetase would lead to a low level of TD activity. Newly formed threonine could conceivably be further metabolized to a-ketobutyrate while the metabolite remains bound to pyridoxal phosphate.
A somewhat analogous type of suppression was found in arginine-proline auxotrophs of E. coli W (6) . The interaction of a structural gene mutation with a mutation affecting regulation was also involved; however, the similarity is only superficial. In the presence of limiting concentrations of arginine, derepression of the enzymes involved in arginine biosynthesis occurs in the absence of a regulatory gene mutation. Derepression of the enzymes of arginine biosynthesis and a genetic alteration of acetylornithine-y-transaminase leads to the accumulation of N-acetylglutamic-y-semialdehyde. This latter compound can be slowly deacylated to glutamic semialdehyde because of a broad specificity (or secondary deacylase activity) of acetylomithinase. Glutamic semialdehyde is readily converted to proline, because the genetic block in these mutants affects a step in proline biosynthesis that precedes the formation of this precursor. The authors emphasize the role of derepression in leading to an adequate pool size of N-acetylglutamic-ysemialdehyde for the deacylase activity of acetylorinithinase to have a phenotypic effect. However, an examination of the data of Itakawa et al. (6) , prompted by the findings in the present studies, reveals that there is also an inadequate in vitro deacylase activity obtained from cells that are not derepressed for acetylornithinase.
Skarstedt and Greer (manuscript in preparation) have shown that the minor TD activity described in this and a previous paper (14) is an associated activity of threonine synthetase; indeed, genetic and biochemical studies indicate that threonine synthetase and the minor TD are activities of the same protein.
The secondary TD activity of an enzyme such as threonine synthetase could reflect structural homologies between TS and the major TD leading to a degree of analogy. This might be expected in two pyridoxal phosphate enzymes that are adjacent in a biochemical pathway, if their origins involved gene duplication and mutation.
